CONTACT US
CONTACT US

February 18, 2019

Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up

Background

The management of chondral disease poses challenges due to its poor healing potential. Biomechanical and biological changes can accelerate degeneration, leading to end-stage osteoarthritis (OA).

Conservative Therapies

Various conservative treatments are utilized before surgery, including non-pharmacological interventions and intra-articular therapies. Mesenchymal stem cells (MSCs), particularly from adipose tissue, show promise in cartilage regeneration due to their anti-inflammatory and regenerative properties.

Methods

The study, approved by the Ethics Committee, involved 30 patients with diffuse degenerative chondral lesions treated with autologous micro-fragmented adipose tissue between January and December 2014. Clinical evaluations were conducted at 3 years post-treatment.

Findings

Of the 30 patients, 24 underwent associated surgeries, while 6 had arthroscopy alone. At 3 years, 23% of patients received additional treatments. No adverse events were reported.

Results

Patients not requiring additional treatments maintained outcomes observed at 1 year, with significant improvements in functional scores including Tegner Lysholm Knee, VAS pain, IKDC subjective, and total KOOS.

Discussion

The study demonstrates sustained benefits of autologous micro-fragmented adipose tissue in treating diffuse degenerative knee chondral lesions at mid-term follow-up, supporting its role as an adjunct in surgical procedures.

Conclusion

Micro-fragmented adipose tissue shows promise in mitigating chondral degeneration, warranting further investigation into its protective effects in knee OA management.

References.

  1. Ährlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M (2009) Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 4(1):20–26View ArticleGoogle Scholar
  2. Arcidiacono JA, Blair JW, Benton KA (2012) US Food and Drug Administration international collaborations for cellular therapy product regulation. Stem Cell Res Ther 3(5):1View ArticleGoogle Scholar
  3. Bonasia DE, Dettoni F, Sito G, Blonna D, Marmotti A, Bruzzone M, Castoldi F, Rossi R (2014) Medial opening wedge high tibial osteotomy for medial compartment overload/arthritis in the varus knee: prognostic factors. Am J Sports Med 42(3):690–698View ArticleGoogle Scholar
  4. Caplan AI (2008) All MSCs are pericytes? Cell Stem Cell 3(3):229–230View ArticleGoogle Scholar
  5. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11–15View ArticleGoogle Scholar
  6. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084View ArticleGoogle Scholar
  7. De Girolamo L, Kon E, Filardo G, Marmotti A, Soler F, Peretti G, Vannini F, Madry H, Chubinskaya S (2016) Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc 24(6):1826–1835View ArticleGoogle Scholar
  8. Pak J, Lee JH, Kartolo WA, Lee SH (2016) Cartilage regeneration in human with adipose tissue-derived stem cells: current status in clinical implications. Biomed Res Int 2016:4702674View ArticleGoogle Scholar
  9. Røtterud JH, Risberg MA, Engebretsen L, Årøen A (2012) Patients with focal full-thickness cartilage lesions benefit less from ACL reconstruction at 2–5 years follow-up. Knee Surg Sports Traumatol Arthrosc 20(8):1533–1539View ArticleGoogle Scholar
  10. Ruetze M, Richter W (2014) Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity. Expert Rev Mol Med 16:e9View ArticleGoogle Scholar
  11. Russo A, Condello V, Madonna V, Guerriero M, Zorzi C (2017) Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. J Exp Orthop 4(1):33View ArticleGoogle Scholar
  12. Saithna A, Kundra R, Getgood A, Spalding T (2014) Opening wedge distal femoral varus osteotomy for lateral compartment osteoarthritis in the valgus knee. Knee 21(1):172–175View ArticleGoogle Scholar
  13. Sensebé L, Bourin P, Tarte K (2010) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22(1):19–26View ArticleGoogle Scholar
  14. Su X, Li C, Liao W, Liu J, Zhang H, Li J, Li Z (2018) Comparison of arthroscopic and conservative treatments for knee osteoarthritis: a 5-year retrospective comparative study. Arthroscopy 34(3):652–659View ArticleGoogle Scholar
  15. Verdonk R, Madry H, Shabshin N, Dirisamer F, Peretti GM, Pujol N, Spalding T, Verdonk P, Seil R, Condello V (2016) The role of meniscal tissue in joint protection in early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24(6):1763–1774View ArticleGoogle Scholar

Related Posts

Global Stem Cells Group and ReGen Forge Partnership with Churchill Aesthetic Center in Brussels, Belgium
Inauguration Ceremony Marks Landmark Occasion for Regenerative Medicine in theRegion April 22,...
Read More
International Society for Stem Cell Application Presents International Certification in Cellular Therapies Training in Seoul, Korea
The International Society for Stem Cell Application (ISSCA) proudly announces the upcoming...
Read More
International Society for Stem Cell Application (ISSCA) Returns to Peru with WorldConference on Regenerative Medicine and Cellular Therapies
Miami, Florida – The International Society for Stem Cell Application (ISSCA), adistinguished...
Read More
Privacy Policy           Terms of Service         2025.All rights reserved.

Datran Center. 9100 S. Dadeland Boulevard, Suite 1500. Miami Fl. 33156. United States
Open chat
Have questions?
Get in contact with us...
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram